Effects of Isoflavone Dietary Supplementation on Cardiovascular Risk Factors in Type 2 Diabetes
- Susana González, MRCP1,
- Vijay Jayagopal, MD2,
- Eric S. Kilpatrick, MD3,
- Tom Chapman, FR PHARM S4 and
- Stephen L. Atkin, PHD1
- 1Department of Medicine, University of Hull, Hull, U.K.
- 2Department of Medicine, York General Hospital, York, U.K.
- 3Department of Biochemistry, Hull Royal Infirmary, Hull, U.K.
- 4Essential Nutrition, Brough, U.K.
- Address correspondence and reprint requests to Dr. Susana González, Huddersfield NHS Trust, Acre Street, Huddersfield, HD3 3EA, U.K. Email: ucm_sg{at}hotmail.com
Article Information
vol. 30 no. 7 1871-1873
PubMed
Published By
Print ISSN
Online ISSN
History
- April 18, 2007
- December 15, 2006
- Published in print June 27, 2007.
- Published online ahead of print April 27, 2007.
Article Versions
- Previous version (April 27, 2007 - 13:11).
- You are viewing the most recent version of this article.
Copyright & Usage
DIABETES CARE
Author Information
- Susana González, MRCP1,
- Vijay Jayagopal, MD2,
- Eric S. Kilpatrick, MD3,
- Tom Chapman, FR PHARM S4 and
- Stephen L. Atkin, PHD1
- 1Department of Medicine, University of Hull, Hull, U.K.
- 2Department of Medicine, York General Hospital, York, U.K.
- 3Department of Biochemistry, Hull Royal Infirmary, Hull, U.K.
- 4Essential Nutrition, Brough, U.K.
- Address correspondence and reprint requests to Dr. Susana González, Huddersfield NHS Trust, Acre Street, Huddersfield, HD3 3EA, U.K. Email: ucm_sg{at}hotmail.com
Statistics from Altmetric.com
Article usage
In this Issue
July 2007, 30(7)
Effects of Isoflavone Dietary Supplementation on Cardiovascular Risk Factors in Type 2 Diabetes
